Phase 1 Lymphocytes Clinical Trials

2 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–2 of 2 trials

Recruiting

Phase 1

Tumor Infiltrating Lymphocyte Therapy for Pediatric High Risk Solid Tumors

Lymphocytes

H. Lee Moffitt Cancer Center and Research Institute30 enrolled1 locationNCT06047977

Recruiting

Phase 1

Study on the Safety and Tolerability of PD-1 Knockout Tumor-infiltrating T Cells (TILs) in the Treatment of Advanced Colorectal Cancer

Colorectal Cancer (CRC)PD-1Tumor Infiltrating Lymphocytes

Ruijin Hospital29 enrolled1 locationNCT07035002